7 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35247917 | Diaminobutoxy-substituted Isoflavonoid (DBI-1) Enhances the Therapeutic Efficacy of GLUT1 Inhibitor BAY-876 by Modulating Metabolic Pathways in Colon Cancer Cells. | 2022 May 4 | 2 |
2 | 34869036 | A Novel Microcrystalline BAY-876 Formulation Achieves Long-Acting Antitumor Activity Against Aerobic Glycolysis and Proliferation of Hepatocellular Carcinoma. | 2021 | 1 |
3 | 34906161 | TRIM38 triggers the uniquitination and degradation of glucose transporter type 1 (GLUT1) to restrict tumor progression in bladder cancer. | 2021 Dec 14 | 1 |
4 | 32826891 | GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer. | 2020 Aug 21 | 1 |
5 | 30861255 | Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer. | 2019 May | 1 |
6 | 30602670 | Ovarian Cancer Relies on Glucose Transporter 1 to Fuel Glycolysis and Growth: Anti-Tumor Activity of BAY-876. | 2018 Dec 31 | 5 |
7 | 27552707 | Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876. | 2016 Oct 19 | 1 |